Publications by authors named "Jonathan Haddad"

Claim this Profile
R
Review of Recent Pharmacoepidemiologic Post-Market Safety Studies Through the Lens of the Estimand Framework.
Yong Ma, Jonathan Haddad, Wei Liu, Ellen Snyder, Dimitri Bennett

Ther Innov Regul Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Review of Recent Pharmacoepidemiologic Post-Market Safety Studies Through the Lens of the Estimand Framework.
Yong Ma, Jonathan Haddad, Wei Liu, Ellen Snyder, Dimitri Bennett

Ther Innov Regul Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous signs of rheumatic diseases in skin of colour: are we failing our patients?
Jonathan Haddad, Ian Coulson, G Omondi Oyoo, Robert J Moots

Rheumatology (Oxford)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Fixation During the Acute Phase of Deep Burned Hands: Description of Saint Louis' Burn Center Technique.
Kevin Serror, Marc Chaouat, Sarah Chatelain, Marie Charlotte Dutot, Jonathan Haddad

J Burn Care Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 10-Year Follow-Up Experience of 383 Patients with Bilateral Smooth Inflatable Breast Implants Filled with Saline Solution.
Maurice Mimoun, Nathaniel Malca, Marc Chaouat, Marie-Charlotte Dutot, Jonathan Haddad

Aesthetic Plast Surg· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013.
Moman A Mohammad, Sofia Karlsson, Jonathan Haddad, Björn Cederberg, Tomas Jernberg

BMJ· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Breast Conservation Therapy Defects with Brava and Fat Grafting: Technique, Outcomes, and Safety Profile.
David Boccara, Jonathan Haddad, Marc Chaouat, Kevin Serror, Maurice Mimoun

Plast Reconstr Surg· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis.
James G Krueger, Mayte Suárez-Fariñas, Inna Cueto, Artemis Khacherian, Robert Matheson, Jonathan Haddad

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis.
Bruce E Sands, Shashidhar Joshi, Jonathan Haddad, Johannes M Freudenberg, Deepa Elizabeth Oommen

Inflamm Bowel Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes.
Arun Baksi, Oleg Kraydashenko, Alsu Zalevkaya, Roman Stets, Peter Elliott, Jonathan Haddad

Br J Clin Pharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk assessment in pharmaceutical research and development.
Jonathan Haddad

Pharm Stat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers.
Vincenzo Libri, Andrew P Brown, Giulio Gambarota, Jonathan Haddad, Gregory S Shields

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma.
Steven O'Day, Rene Gonzalez, David Lawson, Robert Weber, Laura Hutchins, Jonathan Haddad

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis